Addition of Vandetanib to Standard Therapy Pegliposomal Doxorubicin (PLD)
Clinical trial NCT00862836 · TERMINATED
Trial details
- NCT number
- NCT00862836
- Sponsor
- Genzyme, a Sanofi Company
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2010-09-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.